Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 5, 2016
Patent Application Number
13811059
Date Filed
July 20, 2011
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention involves compounds of structural Formula (I) and the pharmaceutically acceptable salts thereof. The compounds of the invention are effective at selectively inhibiting CYP11B2, and are therefore useful for the treatment or prophylaxis of disorders that are associated with elevated aldosterone levels, including, but not limited to, hypertension and heart failure.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
